Literature DB >> 6990634

Virus synthesis and replication: reovirus vs. vaccinia virus.

W K Joklik.   

Abstract

The strategies with which two viral genomes that consist of double-stranded nucleic acid express themselves in infected cells are compared. The reovirus genome comprises ten segments of double-stranded RNA, each of which is, in essence, a gene. Each is transcribed into plus-stranded RNA which has two functions: to serve as messenger RNA for the synthesis of the ten reovirus "primary" proteins, and to serve as template for the synthesis of minus-strands with which they remain associated, thereby giving rise to progeny double-stranded RNA. One of the most fascinating unsolved features of the reovirus multiplication cycle is the nature of the mechanism that ensures that each progeny virus particle contains a complete set of the ten individual genome RNA segments. The vaccinia virus genome is a linear molecule of double-stranded DNA which possesses sizable terminal redundancies (up to 7 percent, depending on the strain). The vaccinia virus multiplication cycle can be divided into a well-defined early and late period. During the early period, infecting virus particles are first uncoated to cores within which some 40-50 percent of the viral genome is transcribed. These cores are then uncoated further to naked viral DNA, a process that is mediated by protein(s) translated from the "core" messenger RNA. The overall transcription pattern in highly complex and is regulated both at the transcriptional as well as at the translational level. The most profound program changes occur at the time when DNA replication begins, when the transcription of "early" messenger RNAs, some of which are translated into "early" enzymes, gives way to that of "late" messenger RNAs, most of which are translated into structural virus components.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6990634      PMCID: PMC2595841     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  43 in total

1.  The induction of interferon by temperature-sensitive mutants of reovirus, UV-irradiated reovirus, and subviral reovirus particles.

Authors:  M H Lai; W K Joklik
Journal:  Virology       Date:  1973-01       Impact factor: 3.616

2.  Identification of the nucleotide sequences of the oligonucleotides present in reovirions.

Authors:  J L Nichols; A R Bellamy; W K Joklik
Journal:  Virology       Date:  1972-08       Impact factor: 3.616

3.  An ultrastructural study of virions and cores of reovirus type 3.

Authors:  R B Luftig; S S Kilham; A J Hay; H J Zweerink; W K Joklik
Journal:  Virology       Date:  1972-04       Impact factor: 3.616

4.  Methylated messenger RNA synthesis in vitro by purified reovirus.

Authors:  A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

5.  5'-terminal nucleotide sequence of reovirus mRNA synthesized in vitro.

Authors:  J L Nichols; A J Hay; W K Joklik
Journal:  Nat New Biol       Date:  1972-01-26

6.  Incorporation of in vitro synthesized reovirus double-stranded ribonucleic acid into virus corelike particles.

Authors:  S Sakuma; Y Watanabe
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

7.  Studies on the effect of chymotrypsin on reovirions.

Authors:  W K Joklik
Journal:  Virology       Date:  1972-09       Impact factor: 3.616

8.  The mechanisms of reovirus uncoating and gene activation in vivo.

Authors:  S C Silverstein; C Astell; D H Levin; M Schonberg; G Acs
Journal:  Virology       Date:  1972-03       Impact factor: 3.616

9.  Reovirus morphogenesis. Corelike particles in cells infected at 39 degrees with wild-type reovirus and temperature-sensitive mutants of groups B and G.

Authors:  E M Morgan; H J Zweerink
Journal:  Virology       Date:  1974-06       Impact factor: 3.616

10.  Shythesis of reovirus oligo adenylic acid in vivo and in vitro.

Authors:  S C Silverstein; C Astell; J Christman; H Klett; G Acs
Journal:  J Virol       Date:  1974-03       Impact factor: 5.103

View more
  3 in total

1.  Bio-distribution study of Reolysin® (pelareorep) through a single intravenous infusion in Sprague-Dawley rats.

Authors:  Romit Chakrabarty; Hue Tran; Iohann Boulay; Tanya Moran; Audrey Parenteau; Robert Tavcar; Maude Bigras; Allison Hagerman; Sarah Serl; Brad Thompson; Matt Coffey
Journal:  Invest New Drugs       Date:  2013-12       Impact factor: 3.850

2.  Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization.

Authors:  Nissin Moussatche; Richard C Condit
Journal:  Virology       Date:  2014-12-08       Impact factor: 3.616

3.  Progress in clinical virology--1960 to 1980: a recollection of twenty years.

Authors:  G D Hsiung
Journal:  Yale J Biol Med       Date:  1980 Jan-Feb
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.